A 9-year-old child with rhabdomyosarcoma is receiving combin…
A 9-year-old child with rhabdomyosarcoma is receiving combination chemotherapy with vincristine, doxorubicin, and cyclophosphamide (VAC regimen). The child has an implanted venous access port. During administration of doxorubicin, the nurse notes swelling and erythema at the port site and the child reports burning pain.Which action by the nurse is most appropriate based on the pharmacologic properties of this regimen?